This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Cabot (CBT) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Misses Earnings and Sales Estimates in Q3
by Zacks Equity Research
Lower volumes, unfavorable product mix and a competitive pricing environment impacts Cabot's (CBT) Performance Chemicals unit in Q3.
New Strong Sell Stocks for August 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Earnings Preview: Cabot (CBT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot Completes Placement of Air Emission Control Equipment
by Zacks Equity Research
Cabot (CBT) is on course to conclude the project ahead of the EPA-set deadline despite the challenges posed by Hurricane Barry and the COVID-19 pandemic.
Cabot (CBT) Up 43% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Amends Credit Facilities to Increase Flexibility
by Zacks Equity Research
Cabot (CBT) expects to increase the maximum leverage ratio to provide additional flexibility beyond the coronavirus outbreak-related stress test scenarios.
Cabot (CBT) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Cabot (CBT) expects demand to be low in the fiscal third quarter due to the impacts of the coronavirus pandemic.
Cabot (CBT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 8.45% and -8.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cabot (CBT) Completes Acquisition of SUSN for $115 Million
by Zacks Equity Research
The integration of Cabot's (CBT) portfolio of energy materials and SUSN is expected to create a business that generates sales of around $50 million.
Cabot (CBT) Withdraws FY20 View Amid Coronavirus Pandemic
by Zacks Equity Research
Cabot (CBT) expects financial results to be solid for the fiscal second quarter. However, it is withdrawing the previous financial guidance for fiscal 2020.
Why Is Cabot (CBT) Down 10.9% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moving Average Crossover Alert: Cabot
by Zacks Equity Research
Cabot Corporation (CBT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Cabot Launches Engineered Elastomer Composites Solutions
by Zacks Equity Research
Cabot's (CBT) E2C solutions are geared to raise the bar in tire performance, while offering tire production efficiencies.
Cabot's (CBT) Earnings and Revenues Trail Estimates in Q1
by Zacks Equity Research
Lower volumes hurt Cabot's (CBT) Reinforcement Materials segment in Q1.
Cabot (CBT) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -9.21% and -8.40%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) to Purchase Shenzhen Sanshun Nano New Materials
by Zacks Equity Research
Cabot (CBT) expects the acquisition to deliver innovative solutions that facilitate better battery performance at an optimized price-to-performance ratio.
Cabot (CBT) Down 8.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot Inaugurates Carbon Black Expansion Project in Indonesia
by Zacks Equity Research
Cabot's (CBT) capacity expansion project in Indonesia is part of a broader global capacity expansion and debottlenecking project.
Cabot (CBT) Earnings and Sales Fall Short Of Estimates in Q4
by Zacks Equity Research
Cabot (CBT) witnesses weakness in the China business and global automobile production in fourth-quarter fiscal 2019.
Cabot's New TECHBLAK 85 Series to Meet Sustainability Needs
by Zacks Equity Research
Cabot (CBT) unveils new black masterbatch series, designed to minimize industry's carbon footprint and advance circular economy of plastic raw materials.
Cabot (CBT) Boosts Advanced Carbon Portfolio With ATHLOS CNS
by Zacks Equity Research
Cabot's (CBT) latest conductive carbon additive, ATHLOS CNS, aims at facilitating easier processing of high-performance plastic applications.
Cabot (CBT) Opens Fumed Silica Manufacturing Plant in China
by Zacks Equity Research
The new facility enables Cabot (CBT) to maintain its leadership and become the largest provider of fumed silica in the Chinese market.